IndiaMart
FIEO
Cagrilintide 2.5mg + Semaglutide 5mg (5mg blend) is a dual-action peptide formulation designed for research on weight management, obesity control, and metabolic regulation. Combining Cagrilintide, an amylin analogue, with Semaglutide, a GLP-1 receptor agonist, this formulation offers a synergistic effect on appetite suppression, energy balance, and glucose regulation — making it one of the most promising compounds for metabolic and endocrinological research.
BLUEPILL EXPRESS, a leading merchant exporter, supplies this Cagrilintide + Semaglutide peptide blend under GMP-certified manufacturing in India and China, based on client preference. Each batch undergoes rigorous laboratory testing for purity, potency, and stability, ensuring pharmaceutical-grade consistency for global research use.
Key Features of Cagrilintide 2.5mg + Semaglutide 5mg:
- Advanced dual peptide formulation for research use
- Combines amylin analogue (Cagrilintide) and GLP-1 agonist (Semaglutide)
- Supports studies on obesity, metabolic regulation, and weight loss
- Enhances research on glucose control and energy metabolism
- Manufactured in India and China under GMP-certified facilities
- Exported globally by BLUEPILL EXPRESS – leading merchant exporter
- Available in bulk, OEM, and private label supply formats
- Supplied with COA, MSDS, and full export documentation
- Ideal for biotech, pharmacological, and clinical research institutions
BLUEPILL EXPRESS specializes in the manufacturing and global export of research-grade peptides including Cagrilintide + Semaglutide blends, BPC-157, CJC-1295, TB500, and more. With dual production bases in India and China, we provide flexible manufacturing solutions, cost-effective pricing, and worldwide logistics support.
Partnering with BLUEPILL EXPRESS ensures access to premium peptide quality, GMP-compliant manufacturing, and reliable export services for all your pharmaceutical research and peptide sourcing needs.
